Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00389675
Brief Title: DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension (Darusentan)

First Submitted : October 17, 2006
First Submitted that Met QC Criteria : October 18, 2006
First Posted : October 19, 2006 (Estimate)

Certification/Extension First Submitted : January 3, 2014
Certification/Extension First Submitted that Met QC Criteria : January 3, 2014
Certification/Extension First Posted : January 6, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : January 3, 2014
Last Update Posted : January 6, 2014 (Estimate)